Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals

被引:35
作者
Burastero, SE
Gaffi, D
Lopalco, L
Tambussi, G
Borgonovo, B
DeSantis, C
Abecasis, C
Robbioni, P
Gasparri, A
Lazzarin, A
Celada, F
Siccardi, AG
Beretta, A
机构
[1] DIBIT, San Raffaele Scientific Institute, 20132 Milan, 58, Via Olgettina
关键词
D O I
10.1089/aid.1996.12.273
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study was to investigate the presence and the fine specificity of anti-CD4 autoantibodies in seronegative subjects sexually exposed to HIV-1. Anti-CD4 autoantibodies were previously detected in a fraction of HIV-1-seropositive individuals, Whole sera, purified IgG fractions, and supernatants of EBV-transformed lymphoblastoid cell lines were analyzed by means of ELISA, Western blot, and by competition assays using monoclonal antibodies with known fine specificities. Anti-CD4 antibodies were found in 6 of 18 individuals exposed to HIV-1 infection and who have been persistently seronegative. These antibodies inhibited HIV-1-driven syncytium formation, did not interfere with the CD4-gp120 interaction, and competed for CD4 binding with two of three anti-CD4 monoclonals with known fine specificities. Moreover, autoantibodies with the same fine specificities were found in the supernatants of oligoclonal EBV-transformed B cell lines derived from these individuals, At variance, in the HIV-1-positive patients included in our study, the anti-CD4 antibody response was directed to a broader panel of epitopes, including those involved in CD4-gp120 interactions. In conclusion, anti-CD4 antibodies specific for defined epitopes of the CD4 molecule are generated in the course of an early immune response to HIV-1 antigens in the absence of other signs of infection, as they can be detected by conventional methods, These autoantibodies may play a protective role either alone or in association with other cellular and humoral factors.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 37 条
[1]  
AMARA A, 1994, AIDS, V8, P711
[2]   SURFACE IMMUNOGLOBULIN-POSITIVE LYMPHOCYTES-T IN HIV-1 INFECTION - RELATIONSHIP TO CD4+ LYMPHOCYTE DEPLETION [J].
ARDMAN, B ;
MAYER, K ;
BRISTOL, J ;
RYAN, M ;
SETTLES, M ;
LEVY, E .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 56 (02) :249-258
[3]   HIV-RELATED THROMBOCYTOPENIA [J].
BLOCKMANS, D ;
VERMYLEN, J .
ACTA CLINICA BELGICA, 1992, 47 (02) :117-123
[4]   LYMPHOCYTE PROLIFERATIVE RESPONSES TO HIV-1 ENVELOPE AND CORE ANTIGENS BY INFECTED AND UNINFECTED ADULTS AND CHILDREN [J].
BORKOWSKY, W ;
KRASINSKI, K ;
MOORE, T ;
PAPAEVANGELOU, V .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (05) :673-678
[5]   MONOREACTIVE HIGH-AFFINITY AND POLYREACTIVE LOW AFFINITY RHEUMATOID FACTORS ARE PRODUCED BY CD5+ B-CELLS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
BURASTERO, SE ;
CASALI, P ;
WILDER, RL ;
NOTKINS, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :1979-1992
[6]   ANTIBODY RAISED AGAINST SOLUBLE CD4-RGP120 COMPLEX RECOGNIZES THE CD4 MOIETY AND BLOCKS MEMBRANE-FUSION WITHOUT INHIBITING CD4-GP120 BINDING [J].
CELADA, F ;
CAMBIAGGI, C ;
MACCARI, J ;
BURASTERO, S ;
GREGORY, T ;
PATZER, E ;
PORTER, J ;
MCDANAL, C ;
MATTHEWS, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) :1143-1150
[7]   BIOLOGICAL PROPERTIES OF ANTI-CD4 AUTOANTIBODIES PURIFIED FROM HIV-INFECTED PATIENTS [J].
CHAMS, V ;
IDZIOREK, T ;
KLATZMANN, D .
AIDS, 1991, 5 (05) :565-569
[8]   PROTECTION IN SIMIAN IMMUNODEFICIENCY VIRUS VACCINATED MONKEYS CORRELATES WITH ANTI-HLA CLASS-I ANTIBODY-RESPONSE [J].
CHAN, WL ;
RODGERS, A ;
HANCOCK, RD ;
TAFFS, F ;
KITCHIN, P ;
FARRAR, G ;
LIEW, FY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1203-1207
[9]  
CHENYER R, 1992, EUR J IMMUNOL, V22, P2211
[10]   EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC T-HELPER CELL RESPONSES BEFORE DETECTION OF INFECTION BY POLYMERASE CHAIN-REACTION AND SERUM ANTIBODIES [J].
CLERICI, M ;
BERZOFSKY, JA ;
SHEARER, GM ;
TACKET, CO .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) :178-182